|
rat |
5 |
|
6-hydroxydopamine |
4 |
|
balanced detection |
4 |
|
biomedical problems |
4 |
|
cell biology |
4 |
|
chemobrain |
4 |
|
clinical translation |
4 |
|
coherent raman scattering |
4 |
|
cp: neuroscience |
4 |
|
cytokines |
4 |
|
dendritic spine |
4 |
|
environmentally sensitive |
4 |
|
fear extinction |
4 |
|
fear learning |
4 |
|
fmrp |
4 |
|
frontal association cortex |
4 |
|
gephyrin |
4 |
|
ginsenoside rg1 |
4 |
|
in vivo two-photon imaging |
4 |
|
kif5b |
4 |
|
kinesin-1 |
4 |
|
mouse |
4 |
|
neuroinflammation |
4 |
|
neuroplasticity |
4 |
|
neuroprotection |
4 |
|
neuroscience |
4 |
|
psd95 |
4 |
|
synaptic protein translocation |
4 |
|
1-methyl-4-phenylpyridinium - toxicity |
3 |
|
alkaline extraction |
3 |
|
alzheimer disease - metabolism - prevention & control |
3 |
|
alzheimer's disease |
3 |
|
amyloid beta-peptides - chemistry - genetics - metabolism |
3 |
|
amyloid beta-peptides - drug effects - metabolism |
3 |
|
amyloid beta-peptides - toxicity |
3 |
|
analysis of variance |
3 |
|
animals |
3 |
|
apoptosis |
3 |
|
arabinogalactan-protein |
3 |
|
autophagy |
3 |
|
bessel beam |
3 |
|
biological markers - analysis |
3 |
|
caspase 3 - metabolism |
3 |
|
catechin - administration and dosage - analogs and derivatives - chemistry - pharmacology |
3 |
|
cell count |
3 |
|
cell differentiation - drug effects |
3 |
|
cell line, tumor |
3 |
|
cells, cultured |
3 |
|
central nervous system agents - administration and dosage - toxicity |
3 |
|
cerebral cortex - cytology |
3 |
|
computerized tomography |
3 |
|
contrast enhancement |
3 |
|
conventional methods |
3 |
|
cytoskeleton |
3 |
|
death associated protein kinase |
3 |
|
differentiation |
3 |
|
dose-response relationship, drug |
3 |
|
drug interactions |
3 |
|
drugs, chinese herbal - pharmacology |
3 |
|
embryo, mammalian |
3 |
|
endoplasmic reticulum |
3 |
|
endoplasmic reticulum - metabolism - ultrastructure |
3 |
|
extended depth of field |
3 |
|
fast volumetric imaging |
3 |
|
fear conditioning |
3 |
|
fear retention |
3 |
|
fructus lycii |
3 |
|
ganoderma lucidum |
3 |
|
green tea polyphenols/egcg |
3 |
|
hippocampus - cytology |
3 |
|
humans |
3 |
|
image structures |
3 |
|
indoles - diagnostic use |
3 |
|
l-lactate dehydrogenase - metabolism |
3 |
|
lateral resolution |
3 |
|
lycium - chemistry |
3 |
|
lycium barbarum |
3 |
|
lysosomes - metabolism - ultrastructure |
3 |
|
medicine, east asian traditional |
3 |
|
mice |
3 |
|
mice, transgenic |
3 |
|
microtubules - metabolism |
3 |
|
models, neurological |
3 |
|
molecular weight |
3 |
|
mpp+ |
3 |
|
multiple orders |
3 |
|
neurites - drug effects - metabolism - pathology |
3 |
|
neuroblastoma |
3 |
|
neuronal apoptosis |
3 |
|
neurons - cytology - drug effects - metabolism |
3 |
|
neurons - cytology - metabolism |
3 |
|
neurons - drug effects |
3 |
|
neurons - drug effects - metabolism - pathology |
3 |
|
neuroprotective agents - administration and dosage - chemistry - pharmacology |
3 |
|
neuroprotective agents - pharmacology |
3 |
|
neurotoxicity |
3 |
|
nocodazole - metabolism |
3 |
|
oxidopamine - administration and dosage - toxicity |
3 |
|
oxidopamine - toxicity |
3 |
|
penetration ability |
3 |
|
peptide fragments - toxicity |
3 |
|
photons |
3 |
|
prodrug/pegcg |
3 |
|
propagation direction |
3 |
|
rats |
3 |
|
rats, sprague-dawley |
3 |
|
reactive oxygen species - metabolism |
3 |
|
recombinant fusion proteins - genetics - metabolism |
3 |
|
reishi - chemistry |
3 |
|
retinoic acid |
3 |
|
return of fear |
3 |
|
side lobes |
3 |
|
signal transduction |
3 |
|
signal transduction - drug effects |
3 |
|
synapses - drug effects - metabolism |
3 |
|
synaptophysin |
3 |
|
synaptophysin - drug effects - metabolism |
3 |
|
synaptotoxicity |
3 |
|
transcranial direct current stimulation |
3 |
|
transcranial magnetic stimulation |
3 |
|
tretinoin - pharmacology |
3 |
|
tubulin - metabolism |
3 |
|
tubulin modulators - metabolism |
3 |
|
two-photon microscopy |
3 |
|
vacuoles - metabolism |
3 |
|
volumetric imaging |
3 |
|
β-amyloid |
3 |
|
β-amyloid peptide |
3 |
|
alzheimer's disease - chemotherapy. |
2 |
|
amyloid beta-protein. |
2 |
|
apoptosis. |
2 |
|
double-stranded rna-dependent protein kinase |
2 |
|
eukaryotic initiation factor 2α |
2 |
|
eukaryotic initiation factor-2 |
2 |
|
fear |
2 |
|
ganoderma lucidum - therapeutic use. |
2 |
|
medical sciences |
2 |
|
microrna |
2 |
|
neurodegenerative diseases - metabolism - pathology - physiopathology |
2 |
|
neurons - physiology |
2 |
|
neurons. |
2 |
|
neuroprotective agents. |
2 |
|
neurotoxicology. |
2 |
|
protein biosynthesis - physiology |
2 |
|
protein translation control |
2 |
|
protein transport - physiology |
2 |
|
psychiatry and neurology gerontology and geriatrics |
2 |
|
signal transduction - physiology |
2 |
|
sleep |
2 |
|
slow oscillation |
2 |
|
spindle |
2 |
|
targeted memory reactivation |
2 |
|
verbenaceae - therapeutic use. |
2 |
|
animal cell |
1 |
|
animal experiment |
1 |
|
animal tissue |
1 |
|
association cortex |
1 |
|
auditory cortex |
1 |
|
auditory stimulation |
1 |
|
auditory training |
1 |
|
auditory-cued fear conditioning |
1 |
|
behavior |
1 |
|
conditioning, classical - physiology |
1 |
|
dendritic spine clustering |
1 |
|
dendritic spine plasticity |
1 |
|
dendritic spines - physiology |
1 |
|
digeorge syndrome - complications - genetics - pathology |
1 |
|
extinction, psychological - physiology |
1 |
|
fear - physiology |
1 |
|
hippocampus-related memory |
1 |
|
long-term potentiation - genetics |
1 |
|
long-term synaptic depression - genetics |
1 |
|
neuronal plasticity - physiology |
1 |
|
neurons - pathology - physiology |
1 |
|
plasticity |
1 |
|
prefrontal cortex - pathology |
1 |
